USP13 and chronic myelogenous leukemia, BCR-ABL1 positive: Therefore, we submit that USP10 and USP13 may co-stabilize SKP2, leading to the high protein level of SKP2, which enhances the activation of Bcr-Abl signaling and eliminates p27 to disrupt cell cycle control in CML cells.